Authors:
Lambright, ES
Amin, K
Wiewrodt, R
Force, SD
Lanuti, M
Propert, KJ
Litzky, L
Kaiser, LR
Albelda, SM
Citation: Es. Lambright et al., Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy, GENE THER, 8(12), 2001, pp. 946-953
Authors:
Zhuang, HM
Pourdehnad, M
Lambright, ES
Yamamoto, AJ
Lanuti, M
Li, PY
Mozley, PD
Rossman, MD
Albelda, SM
Alavi, A
Citation: Hm. Zhuang et al., Dual time point F-18-FDG PET imaging for differentiating malignant from inflammatory processes, J NUCL MED, 42(9), 2001, pp. 1412-1417
Authors:
Lambright, ES
Kang, EH
Force, S
Lanuti, M
Caparrelli, D
Kaiser, LR
Albelda, SM
Molnar-Kimber, KL
Citation: Es. Lambright et al., Effect of preexisting anti-herpes immunity on the efficacy of herpes simplex viral therapy in a murine intraperitoneal tumor model, MOL THER, 2(4), 2000, pp. 387-393
Authors:
Xu, KY
Lanuti, M
Lambright, ES
Force, SD
Albelda, SM
Blair, IA
Citation: Ky. Xu et al., A rapid and sensitive method for the quantification of ganciclovirin plasma using liquid chromatography/selected reaction monitoring/mass spectrometry, BIOMED CHRO, 14(2), 2000, pp. 93-98
Authors:
Lanuti, M
Rudginsky, S
Force, SD
Lambright, ES
Siders, WM
Chang, MY
Amin, KM
Kaiser, LR
Scheule, RK
Albelda, SM
Citation: M. Lanuti et al., Cationic lipid : bacterial DNA complexes elicit adaptive cellular immunityin murine intraperitoneal tumor models, CANCER RES, 60(11), 2000, pp. 2955-2963
Authors:
Lambright, ES
Force, SD
Lanuti, ME
Wasfi, DS
Amin, KM
Albelda, SM
Kaiser, LR
Citation: Es. Lambright et al., Efficacy of repeated adenoviral suicide gene therapy in a localized murinetumor model, ANN THORAC, 70(6), 2000, pp. 1865-1870
Authors:
Shrager, JB
Lambright, ES
McGrath, CM
Wahl, PM
Deeb, ME
Friedberg, JS
Kaiser, LR
Citation: Jb. Shrager et al., Lobectomy with tangential pulmonary artery resection without regard to pulmonary function, ANN THORAC, 70(1), 2000, pp. 234-239
Authors:
Lambright, ES
Caparrelli, DJ
Abbas, AE
Toyoizumi, T
Coukos, G
Molnar-Kimber, KL
Kaiser, LR
Citation: Es. Lambright et al., Oncolytic therapy using a mutant type-1 herpes simplex virus and the role of the immune system, ANN THORAC, 68(5), 1999, pp. 1756-1761